Cefditoren (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cefditoren" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

6doi.org

2^nd place

5fda.gov

447^th place

338^th place

3semanticscholar.org

11^th place

8^th place

1mhmedical.com

6,846^th place

4,957^th place

1toku-e.com

low place

1wikigenes.org

low place

1kegg.jp

low place

112buys.com

low place

1web.archive.org

1^st place

12buys.com

Meiact Full Description Archived 2010-09-17 at the Wayback Machine

doi.org

Balbisi EA (October 2002). "Cefditoren, a new aminothiazolyl cephalosporin". Pharmacotherapy. 22 (10): 1278–1293. doi:10.1592/phco.22.15.1278.33481. PMID 12389878. S2CID 23513028.
Blasi F, Concia E, Del Prato B, Giusti M, Mazzei T, Polistena B, et al. (October 2017). "The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach". Journal of Chemotherapy. 29 (5): 274–286. doi:10.1080/1120009X.2017.1291467. PMID 28298164.
Wellington K, Curran MP (2004). "Cefditoren pivoxil: a review of its use in the treatment of bacterial infections". Drugs. 64 (22): 2597–2618. doi:10.2165/00003495-200464220-00009. PMID 15516158. S2CID 46961914.
Barberán J, Aguilar L, Giménez MJ (2012). "Update on the clinical utility and optimal use of cefditoren". International Journal of General Medicine. 5: 455–464. doi:10.2147/IJGM.S25989. PMC 3367410. PMID 22675264.
Uehara S, Sunakawa K, Eguchi H, Ouchi K, Okada K, Kurosaki T, et al. (April 2011). "Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia". Pediatrics International. 53 (2): 264–276. doi:10.1111/j.1442-200x.2010.03316.x. PMID 21648118. S2CID 2209799.
Blasi F, Concia E, Del Prato B, Giusti M, Mazzei T, Polistena B, et al. (October 2017). "The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach". Journal of Chemotherapy. 29 (5): 274–286. doi:10.1080/1120009X.2017.1291467. PMID 28298164.

fda.gov

accessdata.fda.gov

"Spectracef" (PDF). U.S. Food and Drug Administration Prescribing information. Retrieved 20 March 2020.
"Cefditoren Package Insert" (PDF). fda.gov. United States Food and Drug Administration. Retrieved 29 January 2020.
"21-222_Spectracef_microbr" (PDF). Tap holdings inc. 26 June 2001.
"Spectracef (cefditoren pivoxil) Tablets 200 mg and 400 mg" (PDF). U.S. Food and Drug Administration. Retrieved 27 March 2020.
"Cefditoren". fda.gov. United States Food and Drug Administration. Retrieved January 29, 2020.

kegg.jp

"Japanese PI". Kegg Drug. Retrieved 27 March 2020.

mhmedical.com

accessmedicine.mhmedical.com

Macdougall C (2023). "Cell Envelope Disruptors: β-Lactam, Glycopeptide, and Lipopeptide Antibacterials". In Brunton LL, Knollmann BC (eds.). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (14th ed.). McGraw Hill.

nih.gov

pubmed.ncbi.nlm.nih.gov

Balbisi EA (October 2002). "Cefditoren, a new aminothiazolyl cephalosporin". Pharmacotherapy. 22 (10): 1278–1293. doi:10.1592/phco.22.15.1278.33481. PMID 12389878. S2CID 23513028.
Blasi F, Concia E, Del Prato B, Giusti M, Mazzei T, Polistena B, et al. (October 2017). "The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach". Journal of Chemotherapy. 29 (5): 274–286. doi:10.1080/1120009X.2017.1291467. PMID 28298164.
Wellington K, Curran MP (2004). "Cefditoren pivoxil: a review of its use in the treatment of bacterial infections". Drugs. 64 (22): 2597–2618. doi:10.2165/00003495-200464220-00009. PMID 15516158. S2CID 46961914.
Kawamata S, Yamada H, Sato Y, Sasagawa Y, Iwama Y, Matumoto M (June 2010). "[Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media]". The Japanese Journal of Antibiotics. 63 (3): 207–223. PMID 20976878.
Barberán J, Aguilar L, Giménez MJ (2012). "Update on the clinical utility and optimal use of cefditoren". International Journal of General Medicine. 5: 455–464. doi:10.2147/IJGM.S25989. PMC 3367410. PMID 22675264.
Uehara S, Sunakawa K, Eguchi H, Ouchi K, Okada K, Kurosaki T, et al. (April 2011). "Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia". Pediatrics International. 53 (2): 264–276. doi:10.1111/j.1442-200x.2010.03316.x. PMID 21648118. S2CID 2209799.
Blasi F, Concia E, Del Prato B, Giusti M, Mazzei T, Polistena B, et al. (October 2017). "The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach". Journal of Chemotherapy. 29 (5): 274–286. doi:10.1080/1120009X.2017.1291467. PMID 28298164.

ncbi.nlm.nih.gov

Barberán J, Aguilar L, Giménez MJ (2012). "Update on the clinical utility and optimal use of cefditoren". International Journal of General Medicine. 5: 455–464. doi:10.2147/IJGM.S25989. PMC 3367410. PMID 22675264.

semanticscholar.org

api.semanticscholar.org

Balbisi EA (October 2002). "Cefditoren, a new aminothiazolyl cephalosporin". Pharmacotherapy. 22 (10): 1278–1293. doi:10.1592/phco.22.15.1278.33481. PMID 12389878. S2CID 23513028.
Wellington K, Curran MP (2004). "Cefditoren pivoxil: a review of its use in the treatment of bacterial infections". Drugs. 64 (22): 2597–2618. doi:10.2165/00003495-200464220-00009. PMID 15516158. S2CID 46961914.
Uehara S, Sunakawa K, Eguchi H, Ouchi K, Okada K, Kurosaki T, et al. (April 2011). "Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia". Pediatrics International. 53 (2): 264–276. doi:10.1111/j.1442-200x.2010.03316.x. PMID 21648118. S2CID 2209799.

toku-e.com

"Cefditoren sodium Susceptibility and Minimum Inhibitory Concentration (MIC) Data" (PDF). TOKU-E. 22 March 2020.

web.archive.org

Meiact Full Description Archived 2010-09-17 at the Wayback Machine

wikigenes.org

"Disease relevance of Cefditoren". Retrieved June 24, 2014.